HEARTSCIENCES
HeartSciences is advancing the field of electrocardiography through the application of wavelet signal processing and artificial intelligence to develop next generation ECG technology. Wavelet signal processing is currently used in many different industries as an important tool to provide insights and new valuable data related to spectral analysis of a signal. HeartSciences’ MyoVista wavECG Cardiac Testing Device is a 12-lead resting electrocardiograph utilizing continuous wavelet transform (CWT) based signal processing. Patented informatics focus on energy related information rather than conventional voltage-based information. HeartSciences mission is to enable accurate, affordable screening for the early detection of heart disease.
HEARTSCIENCES
Industry:
Artificial Intelligence Health Care Health Diagnostics Medical Device Software
Founded:
2008-01-01
Address:
Southlake, Texas, United States
Country:
United States
Website Url:
http://www.heartsciences.com
Total Employee:
51+
Status:
Active
Contact:
682-237-7781
Total Funding:
31.3 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Liquid Web Gandi.net DNS
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Lark
Lark is a digital health startup that provides virtual care through AI coaching, smart devices, and tele-monitoring.
Pristine Surgical
Pristine Surgical is develops a first-of-its-kind, single-use visualization platform for surgical, diagnostic rigid endoscopic procedures.
Healthily
Healthily is the world’s first medically approved self-care app designed around you.
Current Employees Featured
Andrew Simpson Executive Chairman @ HeartSciences
Executive Chairman
Tess Jackovich VP @ HeartSciences
VP
Founder
Official Site Inspections
http://www.heartsciences.com
- Host name: 104.21.92.64
- IP address: 104.21.92.64
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "HeartSciences"
About Us - HeartSciences
About HeartSciences Radically Increasing the Clinical Value of the ECG Company Overview Mission Statement Team Summary Company Overview Company Overview Mission Statement Team Summary Company Overview …See details»
HeartSciences - Artificial Intelligent …
Dec 29, 2023 HeartSciences is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting worldwide, either via our MyoVista Insights™ cloud-platform using one of the millions of ECG devices currently in …See details»
HeartSciences (Heart Test Laboratories, Inc.) - Crunchbase
Organization. HeartSciences (Heart Test Laboratories, Inc.) Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ...See details»
Management - HeartSciences
TM Trademark of HeartSciences. Reg. US Pat. & TM off. All Rights Reserved. wavECG and wavEKG are trademarks of HeartSciences. MV-WBSTE-001See details»
HeartSciences (NASDAQ:HSCS) | LinkedIn
HeartSciences (NASDAQ:HSCS) Medical Equipment Manufacturing Southlake, Texas 1,161 followers Millions of ECGs are performed every week with technology that hasn't changed in …See details»
HeartSciences
Feb 7, 2023 550 Reserve Street, Suite 360 Southlake, TX 76092 USA Email: info@heartsciences.com Tel: 737-414-9213 Stock Transfer Agent Equiniti Trust Company, …See details»
Contact Us - HeartSciences
Contact Us Reach out to our team if you would like to learn more Inquiries General Email Inquiries: info@heartsciences.com Employment Inquiries: careers@heartsciences.com …See details»
HeartSciences Company Profile - Office Locations, Competitors
Oct 29, 2024 HeartSciences has 1 employees at their 1 location and $18.6 k in annual revenue in FY 2024. See insights on HeartSciences including office locations, competitors, revenue, …See details»
HeartSciences | HeartSciences Provides Business Update and …
Mar 13, 2025 HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG’s …See details»
Invest in HeartSciences Stock | AI-Powered Heart Disease Detection
HeartSciences is focussed on making the ECG (also known as an EKG) far more clinically valuable so that so that it can detect heart disease earlier. We are developing a suite of AI …See details»
HSCS | HeartSciences Inc. Profile - MarketWatch
HeartSciences, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical …See details»
HeartSciences Issues Investor Update Highlighting Recent Key ...
Oct 19, 2023 Andrew Simpson, CEO of HeartSciences, said, "We believe recent announcements fundamentally transform and de-risk HeartSciences. Our agreements with …See details»
HeartSciences | Top Medtech Startup-2022
Andrew Simpson, CEO of HeartSciences, said, “We believe recent announcements fundamentally transform and de-risk HeartSciences. Our agreements with Icahn Mount Sinai is a …See details»
HeartSciences CEO to Participate in the Benzinga All Access Event …
Southlake, Texas, July 13, 2022 (GLOBE NEWSWIRE) — HeartSciences (NASDAQ: HSCS; HSCSW) (“Company”), a medical technology company focused on applying innovative AI …See details»
HeartSciences’ AI-ECG Algorithms Assigned CMS ... - Markets Insider
Nov 13, 2024 HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based …See details»
HeartSciences | Press Releases
Jul 25, 2024 HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runway Ahead of Upcoming FDA Submission. 9/12/2024, 1:00:00 PM. HeartSciences Provides Business …See details»
Chairman & CEO, Andrew Simpson, Describes AI-based …
Oct 19, 2022 Chairman & CEO, Andrew Simpson, Describes AI-based Technology EKG Test and Next Steps for CommercializationSee details»
HeartSciences Announces Major Milestone with the Issuance of …
Oct 19, 2022 Issuance of new reimbursement-related codes expected to accelerate the use and adoption of ECG-based cardiac dysfunction AI algorithms, including HeartSciences’ …See details»
HeartSciences | HeartSciences Provides Business Update and …
Sep 12, 2024 Potential risks and uncertainties include, but are not limited to, risks discussed in HeartSciences' Annual Report on Form 10-K for the fiscal year ended April 30, 2024, filed with …See details»
We sit at the forefront of a brand new era for ECGs. Sound …
Nov 1, 2022 We sit at the forefront of a brand new era for ECGs. Sound dramatic? That’s because it is. People think of the conventional ECG as something that will diagnose you with …See details»